LB Pharma Launches Phase 2 ILLUMINATE-1 Trial for LB-102
26 Jan 2026 //
GLOBENEWSWIRE
LB Pharma Included In Russell 2000 And Russell 3000 Indices
09 Dec 2025 //
GLOBENEWSWIRE
LB Pharmaceuticals to Present Three Posters at 38th ECNP Congress
06 Oct 2025 //
GLOBENEWSWIRE
LB Pharma Appoints William Kane And Rekha Hemrajani To Board
25 Sep 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support